Cuiping Chu

Discovery of 4-phenylindolines containing a (5-cyanopyridin-3-yl)methoxy moiety as potent inhibitors of the PD-1/PD-L1 interaction.

Shaopeng Zhang, Yajing Liu, Mingze Qin, 2022, Bioorganic & medicinal chemistry letters.

Novel 4-Arylindolines Containing a Pyrido[3,2-d]pyrimidine Moiety as the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction Inhibitors for Tumor Immunotherapy.

Shaopeng Zhang, Lihui Wang, Mingze Qin, 2023, Journal of medicinal chemistry.